Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer

High-dose radioiodine outpatient therapy

(2009) Laura Sterian Ward   Arquivos Brasileiros de Endocrinologia e Metabologia

Thyroid Cancer, Thyroiditis and Dietary Iodine: A Review Based on the Salta, Argentina Model

(2008) H. Rubén Harach et al.   ENDOCRINE PATHOLOGY

Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients

(2008) M Chianelli et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

(2008) Ezra E.W. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Sorafenib in Advanced Thyroid Cancer

(2008) Vandana Gupta-Abramson et al.   JOURNAL OF CLINICAL ONCOLOGY

Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with 131I Is Associated with Lowered Radiotoxicity

(2008) P. W. Rosario et al.   JOURNAL OF NUCLEAR MEDICINE

Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer

(2008) W. Jentzen et al.   JOURNAL OF NUCLEAR MEDICINE

Recombinant Human TSH-Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal

(2008) R. M. Tuttle et al.   JOURNAL OF NUCLEAR MEDICINE

A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer

(2007) Nathan A. Pennell et al.   THYROID